摘要 |
The invention relates to new substituted heteroaryls of formula 1 or of formula 1' wherein A is either N or CH, wherein R2 is selected from the group consisting of -C1-3-alkyl, -C1-3-haloalkyl, F, Br, CI, wherein Y is selected from -O- or -CH2-, and wherein R3 is defined as in claim 1, and the pharmaceutically acceptable salts thereof, and the use of these aforementioned compounds for the treatment of diseases such as asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis. |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
HOFFMANN, Matthias;DAHMANN, Georg;GNAMM, Christian;FANDRICK, Daniel;SCOTT, John;MCCARTHY, Clive |